#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mitochondrial DNA depletion Marginal zone lymphoma recurrent Eosinophilic oesophagitis Partial lipodystrophy Infertility female Immune-mediated myositis Retinoblastoma Glomerulonephritis rapidly progressive Renal cancer metastatic Epstein-Barr virus infection Stiff person syndrome Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Blood iron increased Non-Hodgkin's lymphoma unspecified histology indolent Immunoglobulin G4 related disease More trials…

    Learn about Rare Diseases

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Usher’s syndrome – Treatment Hairy cell leukaemia recurrent – Treatment Wiskott-Aldrich syndrome – Diagnostics Activated PI3 kinase delta syndrome – Life with Disease Encephalitis autoimmune – Life with Disease Myxofibrosarcoma – Life with Disease Prader-Willi syndrome – Trials in Disease Haemophagocytic lymphohistiocytosis – Trials in Disease Hereditary hypophosphataemic rickets – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lidocaine Hydrochloride Evolocumab TIL CELLS Daplusiran Psilocybine ILOPROST Vericiguat Lazertinib Lacutamab Cholic Acid Tobramycin Acetylsalicylic Acid Omp65 Azd9550 Posdinemab Galunisertib Sodium Hydrogen Carbonate HYDROGEN PEROXIDE Sevoflurane ASP3082 More therapies…

    Learn about Your Condition

    Dystonic tremor Traumatic pain Familial mediterranean fever Ventricular extrasystoles Perthes disease Testis cancer Dyskinesia Rectal cancer recurrent CADASIL Renal transplant Vulvovaginal pruritus Sarcoma metastatic Non-obstructive cardiomyopathy Aicardi-Goutieres syndrome Vulvovaginal pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Istituto Oncologico Veneto

Istituto Oncologico Veneto

Via Gattamelata 64, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Leuprorelin Acetate
    • Palbociclib
    • Anastrozole
    Austria Belgium Bulgaria Czechia France Germany +7

  • Study on the Safety and Effectiveness of 2-Hydroxyoleic Acid and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • IDROXIOLEIC ACID
    • Temozolomide
    France Italy Spain

  • Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Olaparib
    Austria Belgium France Germany Hungary Iceland +6

  • Study of Olaparib for Patients with Advanced BRCA-Mutated Ovarian Cancer After Initial Platinum-Based Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Olaparib
    France Italy The Netherlands Poland Spain

  • Study of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Fulvestrant
    • Op-1250
    • PALAZESTRANT
    Austria Belgium Bulgaria Czechia France Germany +7

  • Study on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Anagrelide Hydrochloride Monohydrate
    • Bomedemstat
    • Busulfan
    Belgium France Germany Hungary Italy The Netherlands +4

  • Study of Imlunestrant, Fulvestrant, Exemestane, and Abemaciclib for Patients with Advanced Estrogen Receptor Positive, HER2 Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Abemaciclib
    • Fulvestrant
    • Ly3484356
    Austria Belgium France Germany Greece Italy +2

  • Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Giredestrant
    • Palbociclib
    • Letrozole
    Austria Belgium Denmark France Germany Greece +5

  • Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Abiraterone
    • Degarelix
    • Relugolix
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Metastatic Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Abiraterone
    • Degarelix
    • Relugolix
    Belgium Czechia France Germany Hungary Italy +4
Previous Page
1 … 30 31 32 33 34 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!